rss
Br J Ophthalmol 84:259-263 doi:10.1136/bjo.84.3.259
  • Original Article
    • Clinical science

Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland

Table 3

Treatment and relation to visual outcome at 1 year follow up

Visual outcome No (%) of patients
VA ⩾ 6/12 (n=12) VA ⩽ 6/ 60 (n=1) VA improvement ⩾ 2 Snellen lines (n=7)
Adequate and rapid medication 10  (83) 0 6
Enucleation 3 (25) 1 1
Time interval from symptoms to diagnosis
 <2 months 10 (83) 1 5
 ⩾2 months 2 (17) 0 2
  • Active disease treated with immunosuppression/ prednisolone ⩾0.33 mg/kg/day less than 2 weeks after the onset of symptoms.

This Article

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.